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ABSTRACT

Gene chip analysis of ten HNO adapted cell lines (Squamous cells:
SCC-016, SCC-040, SCC-056, SCC-114, SCC-116;
Adenocarcinomas: A549, BT20, Hs578, MCF7, and T47D) was
carried out. Known pseudogenes were identified in each line, as
well as their coding counterparts.
The adenocarcinoma cell lines had no up regulated pseudogenes,
while they had the following down regulated pseudogenes:
RP6-159A1.2, RP11-255N24.3, AC004490.1, LDHBP,
RP11-572H4.2. The squamous cell carcinomas (SCCs) had the
following up regulated pseudogenes: RPL37AP1, AC138972.1,
RP11-641D5.1, AC005534.6, AC022431.1, RPL26P12, and they
had these down regulated pseudogenes: RP6-159A1.2,
RP11-255N24.3, RBMXP1, RP11-20O23.1, RP11-551G24.2. All cell
lines adhered to the hypothesis that an increase in a pseudogene
expression also had an increase in the corresponding gene.
The high level of pseudogenes could be due to low levels of
microRNA; low expression of microRNA could then be due to high
levels of ceRNA. In cases when the pseudogenes increase in
expression (possibly due to HNO interference) they, like BRAF, take
the functionality of ceRNA which in turn decreases microRNA
expression. Although a pseudogene may not have any direct
translational significance, it can act as ceRNA to facilitate the over
expression of the coding gene in a feedback loop.

INTRODUCTION

Although pseudogenes were traditionally thought to have no
functional significance, evidence by Karreth et al. suggests that
pseudogenes may contribute to the development of cancer as ceRNA
(coding endogenous) mediates microRNA sequestration. Karreth et al.
also observed a parallel dysregulation with the BRAF gene and its
pseudogene. Specifically, high levels of the BRAF pseudogene
(entailing a high amount of the regular BRAF gene) lead to the
development of aggressive malignancies similar to human diffuse
large B cell lymphoma. Therefore, pairs of coding genes and their
pseudogenes in oncogenic dysregulation of ten HNO adapted cell
lines needed to be detected in order to better understand the
relationship between genes and pseudogenes.

HYPOTHESIS/OBJECTIVE
With HNO, ceRNA and microRNA are affected such that
pseudogenes (and coding analogs) are overexpressed ultimately
yielding cancer.

METHODS

Gene chip analysis in the Radosevich Lab at UIC allowed the
examination of ten HNO adapted cell lines, five squamous and five
adenocarcinomas (SCC-016, SCC-040, SCC-056, SCC-114,
SCC-116, A549, BT20, Hs578, MCF7, and T47D). Known and
processed pseudogenes were sought in each line as well as coding
counterparts.

RESULTS

Figure 2. Illustrates possible routes of pseudogene
formation as well as the role of ceRNA in its synthesis.

Figure 1. Represents Karreth et al.’s study regarding
BRAF and BRAF pseudogene inception and lead up to
cancer.
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CONCLUSION
Beyond microRNA having a greater affiliation for pseudogenes,
other cellular substances may do the same. The antisense gene
(AC004490.1 in ACC down) could also parallel the processes
between ceRNA, microRNAs, and pseudogenes. The high level of
pseudogenes could be due to low levels of microRNA; low
expression of microRNA could then be due to a high level of ceRNA.
Such symptoms could be hallmarks for cancerous cells.
Moreover, in cases when the pseudogenes increase in expression
(possibly due to HNO interference) they, like BRAF, take the
functionality of ceRNA which in turn decreases microRNA
expression. Hence, although the pseudogene may not have any
translational significance, it acts as ceRNA to facilitate the
overexpression of the coding gene in a feedback loop (and
pseudogene) which leads to oncogenic threats.

The ACC cell line upregulated had no pseudogenes;
ACC down had RP6-159A1.2, RP11-255N24.3,
AC004490.1, LDHBP, RP11-572H4.2; SCC Up had
R P L 3 7 A P 1 , A C 1 3 8 9 7 2 . 1 , R P 11 - 6 4 1 D 5 . 1 ,
AC005534.6 , AC022431.1, RPL26P12; and SCC down
had RP6-159A1.2, RP11-255N24.3 , RBMXP1,
RP11-20O23.1, RP11-551G24.2. All cell lines adhered
to the hypothesis that an increase in a pseudogene
also increased the expression of the corresponding
coding gene.
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